Impact on Opioid Use of Bundling Medication-assisted Treatment With mHealth
Not Applicable
Completed
- Conditions
- Opioid Use Disorder
- Registration Number
- NCT02712034
- Lead Sponsor
- University of Wisconsin, Madison
- Brief Summary
The primary aim of this study is to measure and explain the impact on long-term opioid use when medication-assisted treatment (MAT) is bundled with an evidence-based mobile-health system (A-CHESS).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 417
Inclusion Criteria
- are 18+ years old;
- meet criteria for opioid use disorders of at least moderate severity (4 or 5 DSM-V criteria);
- Are currently taking medication-assisted treatment (MAT) as part of their standard clinical care;
- have no acute medical problem requiring immediate inpatient treatment;
- have no history of psychotic disorders, though those with other co-morbid psychopathology (mood disorders, anxiety, other substance use disorders) will be eligible;
- are willing to participate in a randomized clinical trial;
- provide the name, verified telephone number, and address of at least 2 contacts willing to help locate the patient, if necessary, during follow-up;
- are able to read and write in English;
- are not pregnant;
- are willing to share health-related data with primary care clinicians; and
- are, at study intake, abstinent from opioids for at least 1 week and no longer than 2 months, except for medications used to treat the disorder (e.g., methadone).
Exclusion Criteria
Not provided
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Primary Outcome Measures
Name Time Method Opioid use 24 months Detect the difference in illicit opioid use between patients who have MAT + A-CHESS vs. MAT alone.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Access Community Health Centers
🇺🇸Madison, Wisconsin, United States
Access Community Health Centers🇺🇸Madison, Wisconsin, United States